Scinai Immunotherapeutics Ltd. (SCNI) stock surged +1.52%, trading at $3.57 on NASDAQ, up from the previous close of $3.52. The stock opened at $3.57, fluctuating between $3.55 and $3.73 in the recent session.
Scinai Immunotherapeutics Ltd., a development stage biopharmaceutical company, focuses on developing, manufacturing, and commercializing products for the prevention and treatment of infectious and autoimmune diseases, and other illnesses in Israel. It has licensing and collaboration agreement with Max Planck Society and University Medical Center Göttingen for the development and commercialization of COVID-19 nanosized antibody (NanoAb); and development and commercialization of NanoAbs for various other disease indications. The company was formerly known as BiondVax Pharmaceuticals Ltd. and changed its name to Scinai Immunotherapeutics Ltd. in September 2023. Scinai Immunotherapeutics Ltd. was incorporated in 2003 and is headquartered in Jerusalem, Israel.
Employees | 31 |
Beta | 2.46 |
Sales or Revenue | N/A |
5Y Sales Change% | 0% |
Fiscal Year Ends | N/A |
Sector | Healthcare |
Industry | Biotechnology |
Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) stock price is $3.57 in the last trading session. During the trading session, SCNI stock reached the peak price of $3.73 while $3.55 was the lowest point it dropped to. The percentage change in SCNI stock occurred in the recent session was 1.52% while the dollar amount for the price change in SCNI stock was $0.05.
The NASDAQ listed SCNI is part of Biotechnology industry that operates in the broader Healthcare sector. Scinai Immunotherapeutics Ltd. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
No Data
SCNI's closing price is 60.25% higher than its 52-week low of $2.23 where as its distance from 52-week high of $8.92 is -59.94%.
Number of SCNI employees currently stands at 31.
Official Website of SCNI is: https://www.scinai.com
SCNI could be contacted at phone 972 893 02529 and can also be accessed through its website. SCNI operates from Jerusalem BioPark Building, Jerusalem, , Israel.
SCNI stock volume for the day was 6.04K shares. The average number of SCNI shares traded daily for last 3 months was 10.65K.
The market value of SCNI currently stands at $3.05M with its latest stock price at $3.57 and 853K of its shares outstanding.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com